Skip to main content
Erschienen in: European Radiology 10/2014

01.10.2014 | Urogenital

MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy

verfasst von: Lars Schimmöller, Michael Quentin, Christian Arsov, Andreas Hiester, Christian Buchbender, Robert Rabenalt, Peter Albers, Gerald Antoch, Dirk Blondin

Erschienen in: European Radiology | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study evaluated the accuracy of MR sequences [T2-, diffusion-weighted, and dynamic contrast-enhanced (T2WI, DWI, and DCE) imaging] at 3T, based on the European Society of Urogenital Radiology (ESUR) scoring system [Prostate Imaging Reporting and Data System (PI-RADS)] using MR-guided in-bore prostate biopsies as reference standard.

Methods

In 235 consecutive patients [aged 65.7 ± 7.9 years; median prostate-specific antigen (PSA) 8 ng/ml] with multiparametric prostate MRI (mp-MRI), 566 lesions were scored according to PI-RADS. Histology of all lesions was obtained by targeted MR-guided in-bore biopsy.

Results

In 200 lesions, biopsy revealed prostate cancer (PCa). The area under the curve (AUC) for cancer detection was 0.70 (T2WI), 0.80 (DWI), and 0.74 (DCE). A combination of T2WI + DWI, T2WI + DCE, and DWI + DCE achieved an AUC of 0.81, 0.78, and 0.79. A summed PI-RADS score of T2WI + DWI + DCE achieved an AUC of 0.81. For higher grade PCa (primary Gleason pattern ≥ 4), the AUC was 0.85 for T2WI + DWI, 0.84 for T2WI + DCE, 0.86 for DWI + DCE, and 0.87 for T2WI + DWI + DCE. The AUC for T2WI + DWI + DCE for transitional-zone PCa was 0.73, and for the peripheral zone 0.88. Regarding higher-grade PCa, AUC for transitional-zone PCa was 0.88, and for peripheral zone 0.96.

Conclusion

The combination of T2WI + DWI + DCE achieved the highest test accuracy, especially in patients with higher-grade PCa. The use of ≤2 MR sequences led to lower AUC in higher-grade and peripheral-zone cancers.

Key Points

• T2WI + DWI + DCE achieved the highest accuracy in patients with higher grade PCa
T2WI + DWI + DCE was more accurate for peripheral- than for transitional-zone PCa
DCE increased PCa detection accuracy in the peripheral zone
DWI was the leading sequence in the transitional zone
Literatur
1.
Zurück zum Zitat Murphy G, Haider M, Ghai S et al (2013) The expanding role of MRI in prostate cancer. AJR 201:1229–1238PubMedCrossRef Murphy G, Haider M, Ghai S et al (2013) The expanding role of MRI in prostate cancer. AJR 201:1229–1238PubMedCrossRef
3.
Zurück zum Zitat Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M, Malavaud B (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62:986–996PubMedCrossRef Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M, Malavaud B (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62:986–996PubMedCrossRef
4.
Zurück zum Zitat Kuru TH, Roethke MC, Rieker P, Roth W, Fenchel M, Hohenfellner M, Schlemmer HP, Hadaschik BA (2013) Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate. BJU Int 112:1080–1087PubMedCrossRef Kuru TH, Roethke MC, Rieker P, Roth W, Fenchel M, Hohenfellner M, Schlemmer HP, Hadaschik BA (2013) Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate. BJU Int 112:1080–1087PubMedCrossRef
5.
Zurück zum Zitat Schimmöller L, Quentin M, Arsov C, Lanzman RS, Hiester A, Rabenalt R, Antoch G, Albers P, Blondin D (2013) Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol 23:3185–3190PubMedCrossRef Schimmöller L, Quentin M, Arsov C, Lanzman RS, Hiester A, Rabenalt R, Antoch G, Albers P, Blondin D (2013) Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol 23:3185–3190PubMedCrossRef
6.
Zurück zum Zitat Rosenkrantz AB, Lim RP, Haghighi M, Somberg MB, Babb JS, Taneja SS (2013) Comparison of interreader reproducibility of the prostate imaging reporting and data system and Likert scales for evaluation of multiparametric prostate MRI. AJR 201:601–618 Rosenkrantz AB, Lim RP, Haghighi M, Somberg MB, Babb JS, Taneja SS (2013) Comparison of interreader reproducibility of the prostate imaging reporting and data system and Likert scales for evaluation of multiparametric prostate MRI. AJR 201:601–618
7.
Zurück zum Zitat Westphalen AC, Rosenkartz AB (2014) Prostate Imaging Reporting and Data System (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI. AJR 202:121–123PubMedCrossRef Westphalen AC, Rosenkartz AB (2014) Prostate Imaging Reporting and Data System (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI. AJR 202:121–123PubMedCrossRef
8.
Zurück zum Zitat Mazaheri Y, Shukla-Dave A, Muellner A et al (2008) MR imaging of the prostate in clinical practice. MAGMA 21:379–392PubMedCrossRef Mazaheri Y, Shukla-Dave A, Muellner A et al (2008) MR imaging of the prostate in clinical practice. MAGMA 21:379–392PubMedCrossRef
9.
Zurück zum Zitat Osugi K, Tanimoto A, Nakashima J, Shinoda K, Hashiguchi A, Oya M, Jinzaki M, Kuribayashi S (2013) What is the most effective tool for detecting prostate cancer using a standard MR scanner? Magn Reson Med Sci 12:271–280PubMedCrossRef Osugi K, Tanimoto A, Nakashima J, Shinoda K, Hashiguchi A, Oya M, Jinzaki M, Kuribayashi S (2013) What is the most effective tool for detecting prostate cancer using a standard MR scanner? Magn Reson Med Sci 12:271–280PubMedCrossRef
10.
Zurück zum Zitat Puech P, Sufana-Iancu A, Renard B, Lemaitrea L (2013) Prostate MRI: can we do without DCE sequences in 2013? Diagn Interv Imaging 94:1299–1311PubMedCrossRef Puech P, Sufana-Iancu A, Renard B, Lemaitrea L (2013) Prostate MRI: can we do without DCE sequences in 2013? Diagn Interv Imaging 94:1299–1311PubMedCrossRef
11.
Zurück zum Zitat Sabach A, Babb JS, Matza BW, Taneja SS, Deng FM (2013) Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. AJR 201:471–478CrossRef Sabach A, Babb JS, Matza BW, Taneja SS, Deng FM (2013) Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. AJR 201:471–478CrossRef
12.
Zurück zum Zitat Hoeks CMA, Hambrock T, Yakar D, Hulsbergen-van de Kaa CA, Feuth T, Witjes JA, Fütterer JJ, Barentsz JO (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 266:207–217PubMedCrossRef Hoeks CMA, Hambrock T, Yakar D, Hulsbergen-van de Kaa CA, Feuth T, Witjes JA, Fütterer JJ, Barentsz JO (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 266:207–217PubMedCrossRef
13.
Zurück zum Zitat Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B et al (2011) Magnetic resonance imaging for the detection, localization and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59:477–494PubMedCrossRef Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B et al (2011) Magnetic resonance imaging for the detection, localization and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59:477–494PubMedCrossRef
14.
Zurück zum Zitat Quentin M, Schimmöller L, Arsov C, Rabenalt R, Antoch G, Albers P, Blondin D (2013) Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy. Eur Radiol 24:209–213PubMedCrossRef Quentin M, Schimmöller L, Arsov C, Rabenalt R, Antoch G, Albers P, Blondin D (2013) Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy. Eur Radiol 24:209–213PubMedCrossRef
15.
Zurück zum Zitat Röthke M, Blondin D, Schlemmer HP, Franiel T (2013) PI-RADS classification: structured reporting for MRI of the prostate. Röfo 185:253–261PubMed Röthke M, Blondin D, Schlemmer HP, Franiel T (2013) PI-RADS classification: structured reporting for MRI of the prostate. Röfo 185:253–261PubMed
16.
Zurück zum Zitat Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin P, Kirkham AP, Padhani AR, Persad R, Puech P, Punwani S, Sohaib A, Tombal B, Villers A, Emberton M (2013) Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging 37:48–58PubMedCrossRef Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin P, Kirkham AP, Padhani AR, Persad R, Puech P, Punwani S, Sohaib A, Tombal B, Villers A, Emberton M (2013) Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging 37:48–58PubMedCrossRef
17.
Zurück zum Zitat Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64:713–719PubMedCrossRef Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64:713–719PubMedCrossRef
18.
Zurück zum Zitat Delongchamps NB, Rouanne M, Flam T et al (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107:1411–1418PubMedCrossRef Delongchamps NB, Rouanne M, Flam T et al (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107:1411–1418PubMedCrossRef
19.
Zurück zum Zitat Nagel KN, Schouten MG, Hambrock T, Litjens GJ, Hoeks CM, ten Haken B, Barentsz JO, Fütterer JJ (2013) Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T. Radiology 267:164–172PubMedCrossRef Nagel KN, Schouten MG, Hambrock T, Litjens GJ, Hoeks CM, ten Haken B, Barentsz JO, Fütterer JJ (2013) Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T. Radiology 267:164–172PubMedCrossRef
20.
Zurück zum Zitat Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS, Hricak H, Zelefsky MJ, Akin O (2013) Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 268:440–450PubMedCrossRef Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS, Hricak H, Zelefsky MJ, Akin O (2013) Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 268:440–450PubMedCrossRef
21.
Zurück zum Zitat Isebaert S, Van den Bergh L, Haustermans K et al (2013) Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J Magn Reson Imaging 37:1392–1401PubMedCrossRef Isebaert S, Van den Bergh L, Haustermans K et al (2013) Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J Magn Reson Imaging 37:1392–1401PubMedCrossRef
22.
Zurück zum Zitat Chesnais AL, Niaf E, Bratan F, Mège-Lechevallier F, Roche S, Rabilloud M, Colombel M, Rouvière O (2013) Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI. Clin Radiol 68:323–330CrossRef Chesnais AL, Niaf E, Bratan F, Mège-Lechevallier F, Roche S, Rabilloud M, Colombel M, Rouvière O (2013) Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI. Clin Radiol 68:323–330CrossRef
23.
Zurück zum Zitat Hoeks CMA, Vos EK, Bomers JGR, Barentsz JO, Hulsbergen-van de Kaa CA, Scheenen TW (2013) Diffusion-weighted magnetic resonance imaging in the prostate transition zone. Histopathological validation using magnetic resonance guided biopsy specimens. Investig Radiol 48:693–701CrossRef Hoeks CMA, Vos EK, Bomers JGR, Barentsz JO, Hulsbergen-van de Kaa CA, Scheenen TW (2013) Diffusion-weighted magnetic resonance imaging in the prostate transition zone. Histopathological validation using magnetic resonance guided biopsy specimens. Investig Radiol 48:693–701CrossRef
Metadaten
Titel
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy
verfasst von
Lars Schimmöller
Michael Quentin
Christian Arsov
Andreas Hiester
Christian Buchbender
Robert Rabenalt
Peter Albers
Gerald Antoch
Dirk Blondin
Publikationsdatum
01.10.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 10/2014
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3276-9

Weitere Artikel der Ausgabe 10/2014

European Radiology 10/2014 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.